QUINVERA Trademark

Trademark Overview

On Wednesday, July 17, 2013, a trademark application was filed for QUINVERA with the United States Patent and Trademark Office. The USPTO has given the QUINVERA trademark a serial number of 79134267. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 16, 2023. This trademark is owned by NOVARTIS AG. The QUINVERA trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
quinvera

General Information

Serial Number79134267
Word MarkQUINVERA
Filing DateWednesday, July 17, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 16, 2023
Registration Number4500060
Registration DateTuesday, March 25, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2013

Trademark Statements

Goods and Servicesvaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, February 12, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, February 12, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 3, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, February 24, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, February 24, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Saturday, July 12, 2014NOTIFICATION PROCESSED BY IB
Friday, June 13, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 13, 2014FINAL DISPOSITION PROCESSED
Thursday, April 24, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, February 13, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, November 12, 2013CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Saturday, November 9, 2013CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, October 8, 2013NOTIFICATION PROCESSED BY IB
Tuesday, October 8, 2013EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 1, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 18, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 11, 2013NOTICE OF PUBLICATION
Friday, August 23, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2013APPLICATION FILING RECEIPT MAILED
Monday, August 19, 2013ASSIGNED TO EXAMINER
Friday, August 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

quinvera human vaccines